In the serum of SCAP and MCAP patients, RPPH1 was found to be significantly downregulated, while the expression of RPPH1 in SCAP was dramatically lower than that in the MCAP patients (Fig. 1A). Here, RPPH1 is linked to syringocystadenoma papilliferum.